Association of statin use with osteoporosis risk: a drug-targeted Mendelian randomization study
ConclusionThese evidence supported a protective effect of HMGCR-mediated non-HDL cholesterol reduction or statin use against osteoporosis.
Source: Inflammopharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Cholesterol | Drugs & Pharmacology | Genetics | Men | Orthopaedics | Osteoporosis | Statin Therapy | Study